DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Equagesic (Meprobamate / Aspirin) - Summary

 
 



EQUAGESIC SUMMARY

General

Each tablet of Equagesic, for oral administration, contains 200 mg meprobamate and 325 mg aspirin.

As an adjunct in the short-term treatment of pain accompanied by tension and/or anxiety in patients with musculoskeletal disease. Clinical trials have demonstrated that in these situations relief of pain is somewhat greater than with aspirin alone. Equagesic is not intended for use longer than 10 days.


See all Equagesic indications & dosage >>

NEWS HIGHLIGHTS

Media Articles Related to Equagesic (Meprobamate / Aspirin)

Coordination of Care Matters Most to Patients With Chronic Pain
Source: Medscape NeurologyHeadlines [2015.03.27]
A survey shows patients rank coordination of chronic pain management above the relationship with their healthcare provider, and outcomes correlate with the quality of coordination.
Medscape Medical News

Study identifies low back pain risk factors
Source: Bones / Orthopedics News From Medical News Today [2015.03.27]
Counseling at-risk patients may prevent and minimize painNew research presented at the 2015 Annual Meeting of the American Academy of Orthopaedic Surgeons (AAOS) identifies nicotine dependence...

New technique paints tissue samples with light
Source: Breast Cancer News From Medical News Today [2015.03.27]
One infrared scan can give pathologists a window into the structures and molecules inside tissues and cells, enabling fast and broad diagnostic assessments, thanks to an imaging technique developed...

Researchers discover a key mechanism of chronic inflammatory pain that could reduce drug doses
Source: Neurology / Neuroscience News From Medical News Today [2015.03.27]
A study led by Professor Lucía Hipólito, from the Department of Pharmacy and Pharmaceutical Technology of the University of Valencia, has revealed a new mechanism to treat chronic inflammatory...

Intradiscal Biacuplasty Bests Standard Back Pain Therapy
Source: Medscape NeurologyHeadlines [2015.03.26]
The minimally invasive radiofrequency therapy shows significantly higher rates of pain relief compared with conventional therapy approaches after 6 months in a randomized study.
Medscape Medical News

more news >>


Page last updated: 2015-03-27

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2015